TPM2 gene

Cap myopathy often presents in infancy with severe hypotonia (floppiness) and muscle weakness that is most pronounced in the distal muscles of the legs and arms. A hallmark diagnostic feature is the presence of "caps" of glycogen accumulation at the ends of muscle fibers, which can be identified through muscle biopsy. Clinically, affected individuals may have difficulty with gross motor milestones such as sitting, standing, and walking, and they may exhibit a characteristic high-arched foot (pes cavus) and joint contractures. Unlike some other myopathies, the weakness in cap myopathy is often non-progressive or slowly progressive, and respiratory muscle involvement is generally mild or absent, which helps distinguish it from more severe congenital myopathies. What is the inheritance pattern of TPM2-related disorders, and how does this affect genetic counseling for family planning?::TPM2-related conditions, including cap myopathy, distal arthrogryposis type 1, and Sheldon-Hall syndrome, are inherited in an autosomal recessive pattern. This means that an individual must inherit two mutated copies of the TPM2 gene, one from each parent, to develop the condition. Parents who are carriers typically do not show symptoms but have a 25 percent chance with each pregnancy of having a child affected by the disorder. Genetic counseling is crucial for families with a history of these conditions to understand the recurrence risks and to discuss options for carrier testing and prenatal or preimplantation genetic diagnosis. Can mutations in the TPM2 gene cause symptoms beyond muscle weakness, such as cardiac or respiratory issues?::While TPM2 mutations primarily affect skeletal muscle, leading to weakness and joint contractures, significant cardiac or respiratory complications are not typical features of the condition. The beta-tropomyosin protein is predominantly expressed in skeletal muscle, so the heart and diaphragm are usually spared. However, because muscle weakness can affect the muscles involved in swallowing, some individuals may experience mild dysphagia or feeding difficulties in infancy. Regular monitoring by a multidisciplinary team is still recommended to manage orthopedic issues like scoliosis or hip dislocation, which can arise from muscle imbalance, but cardiac screening is generally not required unless specific symptoms arise. What is the difference between distal arthrogryposis type 1 and Sheldon-Hall syndrome, given that both are linked to TPM2 mutations?::Both distal arthrogryposis type 1 (DA1) and Sheldon-Hall syndrome are caused by mutations in the TPM2 gene and present with joint contractures in the hands and feet. The distinction is often clinical and based on the severity and specific pattern of involvement. DA1 is characterized by mild to moderate contractures of the fingers and toes, often with a "claw hand" appearance, and typically has a milder overall phenotype. Sheldon-Hall syndrome is considered a more severe variant, featuring more pronounced contractures, significant muscle weakness, and potentially more extensive skeletal abnormalities. The overlap in symptoms means that diagnosis often relies on detailed clinical examination and genetic testing to identify the specific mutation, as the severity can vary even within the same family.